发明授权
US07260431B2 Combined remodeling control therapy and anti-remodeling therapy by implantable cardiac device
有权
通过可植入心脏装置的联合重塑控制治疗和抗重塑治疗
- 专利标题： Combined remodeling control therapy and anti-remodeling therapy by implantable cardiac device
- 专利标题（中）： 通过可植入心脏装置的联合重塑控制治疗和抗重塑治疗
-
申请号： US10850341申请日： 2004-05-20
-
公开(公告)号： US07260431B2公开(公告)日： 2007-08-21
- 发明人: Imad Libbus , Bruce H. KenKnight , Julia Moffitt , Yatheendhar D. Manicka
- 申请人： Imad Libbus , Bruce H. KenKnight , Julia Moffitt , Yatheendhar D. Manicka
- 申请人地址： US MN St. Paul
- 专利权人： Cardiac Pacemakers, Inc.
- 当前专利权人： Cardiac Pacemakers, Inc.
- 当前专利权人地址： US MN St. Paul
- 代理机构： Schwegman, Lundberg, Woessner, & Kluth, P.A.
- 主分类号： A61N1/18
- IPC分类号： A61N1/18
摘要：
A method and device for delivering ventricular resynchronization pacing therapy in conjunction with electrical stimulation of nerves which alter the activity of the autonomic nervous system is disclosed. Such therapies may be delivered by an implantable device and are useful in preventing the deleterious ventricular remodeling which occurs as a result of a heart attack or heart failure. The device may perform an assessment of cardiac function in order to individually modulate the delivery of the two types of therapy.